----
Current ValuationThe current P/E ratio is 1336.87, above the reasonable range, cheaper than 6.51% of the time in the past 1 years, and the industry ranks 69/605, the industry Median -1.93.
1.337 KxP/E
$5.77Stock price
$0.00Earnings per share
1.337 KxP/E
Stock price$5.77Earnings per share$0.00
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -265.29x
- Typical range
- -565.55x–-259.26x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
03356701,0051,340
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
YDESUSYD Bio | 1,336.87x | -- | $408.76M |
PRTCYUSPURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS | 179.65x | -- | $379.78M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
